ME
Healthcare & Life Sciences
MediMabBio
South Koreawww.medimabbio.com/
MediMabBio is a Healthcare & Life Sciences startup based in South Korea, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About MediMabBio
MediMabBio is a company headquartered in South Korea. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
MediMabBio develops engineered protein-based immunotherapies, including monoclonal antibodies and cytokine-antibody fusion proteins, targeting immune pathways to treat cancer, autoimmune, and inflammatory diseases.
Explore MediMabBio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.